Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ODEVIXIBAT vs OFATUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ODEVIXIBAT vs OFATUMUMAB: Safety Overview

Metric ODEVIXIBAT OFATUMUMAB
Total FAERS Reports 223 29,913
Deaths Reported 10 695
Death Rate 4.5% 2.3%
Hospitalizations 43 3,616
Average Patient Age 14.3 yrs 47.5 yrs
% Female Patients 49.4% 74.9%
FDA Approval Date Jul 20, 2021 N/A
Manufacturer Albireo Pharma, Inc. Novartis Pharmaceuticals Corporation
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription